Biotech Growth N V - Jul 14, 2022 Form 4 Insider Report for ESSA Pharma Inc. (EPIX)

Role: 10%+ Owner
Signature: /s/ Martin Gubler
Stock symbol: EPIX
Transactions as of: Jul 14, 2022
Transactions value $: $1,726,226
Form type: 4
Date filed: 7/18/2022, 12:48 PM
Previous filing: Apr 29, 2022
Next filing: Jul 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EPIX	Common Shares	Purchase	$969K	+347K	+6.96%	$2.79	5.34M	Jul 14, 2022	Direct
transaction	EPIX	Common Shares	Purchase	$757K	+242K	+4.53%	$3.13	5.58M	Jul 15, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of ESSA Pharma Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.